XNAS · HELP
+4.33% · +$0.2700 · Vol 1.9M
After hours · updated 16:43:16 ET
Cybin Inc. Common Stock

Cybin Inc. Common Stock

$6.50
+ Add to watchlist
Card

Veridion Score

Refresh
Score snapshot refresh in progress
Veridion Score History · 90D

Composite trend over time

HISTORY REFRESH IN PROGRESS
REFRESHES DAILY
AI Analysis
Sovereign

Why is HELP moving today?

Sovereign unlock connects news, insider activity, analyst moves, and live price action.
About Cybin Inc. Common Stock
Listed since
2020
Employees
50
Country
US

Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways. The company's programs are aimed at treating mental health conditions such as depression and anxiety. Its pipeline includes HLP003, which is in clinical development for the adjunctive treatment of depressive disorder, and HLP004, which is in clinical development for generalized anxiety disorder. The company also conducts research on additional investigational compounds.

Company website →
Key statistics

Reported fields plus Veridion-computed history. Unsourced tiles are omitted.

Open
$6.16
Day high
$6.73
Day low
$6.05
Previous close
$6.23
52W high
$6.88
-5.52% from high
52W low
$3.87
87% of range
Market cap
$386.2M
Shares out
62M
Volume
1.9M
VWAP
$6.43
Price history computed in-house
1W
+4.17%
1M
+67.96%
SMA 50 $5.39 · above
SMA 200 $5.39 · above
52W position 87%
Veridion warehouse edge

Warehouse intelligence for HELP.

Veridion Score
61
0: 861: 522: 663: 104: 815: Not reported
Congress 30d
0
No recent disclosure on file.
Insider activity
See Form 4 panel below.
13F holders
None on file
Capital Web snapshots checked.
Disclosure-sourced lobbying and contract detail remains attributed in the full panels below.
Data ledger
Quote and day range
Refresh interval: 30 seconds
Source: Market data
Veridion Score
Coverage building
Source: Veridion methodology
Chart and risk context
Daily bars with no missing-bar fill
Source: Market data
News and filings
Refresh intervals shown inside each panel
Source: Market news and federal filings
Financials
Statements refresh in progress
SEC Form 4 ledger

HELP insider activity

Cybin Inc. Common Stock

Score
Coverage building
Pressure
Mixed
Filings
0
Buys / sells
0 / 0
Net value
Not disclosed
Insiders
0
Cluster

No multi-insider buying cluster in the last 90 days

Net pressure

Mixed: Not disclosed across loaded Form 4 rows.

Convergence not established

Loaded official disclosures do not show all three sources aligned on this ticker.

Coverage building

The current Form 4 feed did not return value-bearing open-market rows for HELP.

Source: SEC EDGAR Form 4. Rows with missing price or quantity are excluded rather than zero-filled.Methodology
Congress · 90D
Congress filing snapshot refresh in progress
Federal contracts

HELP contract awards, year to date.

Public federal awards linked to this ticker.

Not disclosed
Refresh interval: 12hSource: Federal contract awards
No federal contracts on file for HELP in this window.
Lobbying spend

HELP lobbying filings, year to date.

Registered lobbying filings matched to Cybin Inc. Common Stock.

Not disclosed
Refresh interval: 12hSource: LDA disclosure filings
No lobbying filings on file for HELP in this window.
Latest news · HELP
Refresh interval: 5 minutes · Source: Market news insights
News snapshot refresh in progress
Analyst ratings
Sovereign unlock shows live analyst consensus for HELP.
Options
Sovereign unlock shows live options positioning for HELP.
Weekly Veridion brief

Rating changes, public disclosure activity, methodology notes, and product updates. One email per week. No advertising list resale.